iX Biopharma Ltd

No reviews yet · Write a Review
iX Biopharma is a specialty pharmaceutical company with expertise in drug delivery systems. The company fully integrated business model, which includes drug formulation, clinical studies, regulatory affairs, manufacturing in Melbourne Australia and sales, provides significant operational benefits from lower cost of sales, enhanced operating efficiencies, better quality control, shorter time-to-market and IP protection.

iX Biopharma has developed WaferiX‚, a sublingual drug delivery platform technology. It uses WaferiX to repurpose existing drugs for new indications and new dosage forms for better efficacy and side effect profile. Leveraging WaferiX, iX Biopharma has developed a line of medicinal cannabis sublingual wafers which it supplies in Australia to patients through medical channels. Its CBD sublingual wafer, Xativa, is the winner of Australia CBD Product of the Year in 2020.

Company Details

Address
Singapore
Singapore, CS

Competitors of iX Biopharma Ltd

Here at SeedMasters.com, we specialize in offering a diverse range of high-quality souvenir cannabis seeds by collaborating with numerous reputable seed banks to ensure discreet, secure, and reliable sourcing for our customers. Our user-friendly online platform is designed to help businesses... Read More

19 Products 0 White Papers 0 Press Releases

We are an Irish manufacturer producing cold-pressed CBD oil that redefines what CBD products can offer in today’s market. Our production method preserves all the hemp plant's properties: over 480 natural compounds including cannabinoids, terpenes, flavonoids, and essential nutrients -delivering the... Read More

1 Product 0 White Papers 0 Press Releases

AZUCA'S TiME INFUSION® changes everything you thought you knew about edibles. Traditional oil-based edibles are processed by the liver, making it impossible, due to variabilities in liver function, to have a predictable experience. TiME INFUSION® creates a unique thermodynamic matrix of... Read More

3 Products 0 White Papers 0 Press Releases